|
Codes: At the end of each Update & Sneak, there are three codes. They have a rating from 1 to 10. Those numbers reflect my personal opinion. Please -- do not take action based on my opinion alone. Do four things before taking action: (1) Read my original writeup to get an overall feel (in the case of updates on recommendations); (2) Get the latest 10-Q, 10-K, corporate profile, & news releases; you can access them at www.wallstreetcorner.com on the Internet; (3) Study them; & (4) Call a key member of management to get a final impression. If anything bothers you regarding that call, pass. There are lots of situations. Do not invest unless everything about a situation feels good to you. "R" stands for "Risk Rating." A "1" means I view the situation as having an extreme amount of risk. A "10" means very low risk -- a much sounder, more financially stable situation. You'll see hardly any with a "1" or "10" rating. I chose "10" to mean lower risk so the higher the number after each of the three codes, the more favorable the rating. "M" stands for "Midterm Appreciation Potential." A "1" means I view the situation as having a small degree of midterm ("mid-term" is six to 12 months) potential. A "10" means really outstanding midterm potential. "L" stands for "Long-term Appreciation Potential." A "1" means I view the situation as having a small degree of long-term ("long-term" is over one year) potential. A "10" means really outstanding long-term potential. Actrade International, Ltd. (NASDAQ/ACRT -- CS 2/99) -- CEO Amos Aharoni, in an interview 4/19/99, was able to explain to me in a very effective way just what his company does. In business, payment is made in either of two ways: cash, or open account with terms. Cash is great for the supplier, hard for the buyer. Open account is great for the buyer, hard for the supplier. In the consumer arena, the solution has been the credit card -- it lets the buyer buy on terms & lets the supplier get cash. In the business to business arena, there hasn't been a way to satisfy both the buyer & the supplier -- until now. ACRT's patented "TAD" (Trade Acceptance Draft) closes the gap between cash & open account. It's the "credit card" of the business to business transaction. It gives the buyer terms & gives the supplier cash. ACRT finances the transaction, takes the credit risk, & handles collections. But the charm of how ACRT does it is that it sells the financing to banks & sells the credit risk to credit insurance companies. ACRT processes the transaction & makes an attractive profit. The buyer is happy; the supplier is delighted; ACRT is making money; the banks love financing the TADs; & the insurance companies generate more revenues -- every party to the TAD business is a winner. Call Mitchell G. Menik @ 212-563-1036, fax 212-563-3271, or write 7 Penn Plaza, Suite 422, New York, NY 10001. www.actrade.com [R-8; M-7; L-8] Advantage Marketing Systems, Inc. (NASDAQ/AM-SO -- CS Sneak 1/99) announced net income for Q4 '98 of $167,626 or $0.04/diluted share compared to a net loss of $2,457 or less than $0.01/diluted share for the same period last year. Net sales increased 48.1% to $3,786,888. Call 800-426-4267 (ext 4916 for Curt Wilson, or ext. 4903 for Roger Baresel), fax 405-843-4935, or write 2601 NW Expressway, Suite 1210W, Oklahoma City, OK 73112 [R-8; M-8; L-9] Air Methods Corp. (NASDAQ NMS/AIRM -- CS 12/91) announced $2.4 million in new contracts for its Products Division. Also, AIRM will re-commence purchasing its common stock. Call CFO Aaron Todd @ 303-792-7413, or write 7301 South Peoria, Englewood, CO 80112. [R-6; M-5; L-7] Allied Devices Corporation (NASDAQ/ALDV -- CS 2/98) announced a common stock buy-back of, initially, up to 100,000 shares. Call Paul Cervino @ 516-223-9100 x238, fax 516-223-9172, or write 2365 Milburn Ave., Baldwin, NY 11510. Website: www.allieddevices.com [R-7; M-7; L-8] AMBI Inc. (NASDAQ/AMBI -- CS 8/95) reported results of clinical trials for Chromax(R) brand chromium picolinate. It reduced or eliminated symptoms of diabetes in 41 out of 44 patients with steroid-induced diabetes. Patients were able to reduce or eliminate their medication & blood sugar levels were also reduced. Call Investor Relations @ 914-701-4545, or write 4 Manhattanville Rd., Purchase, NY 10577. www.AMBIinc.com [R-7; M-6; L-9] |
California Micro Devices Corp. (NASDAQ NMS/CAMD -- CS 10/98) shipped over one billion passive elements to its customers in calendar year 1998... a 70% increase over 1997. Call IR @ 800-325-4966, fax 408-263-7846, or write 215 Topaz St., Milpitas, CA 95035. E-mail: kimk@calmicro.com www.calmicro.com [R-7; M-7; L-8] Empyrean Bioscience, Inc. (formerly Empyrean Diagnostics -- OTC Bulletin Board/EMDG -- CS 6/98) began distribution of its PreventX(R) Hand Sanitizer & Antiseptic Skin Protectant earlier this year. Tests show that this formula suppresses the growth of the HIV virus in a stable human T-cell line. Call CEO Stephen Hayter @ 602-879-6935, or write 2238 West Lone Cactus Dr., Suite 200, Phoenix, AZ 85027. [R-6; M-6; L-7] Galaxy Foods Company (NASDAQ/GAXCD -- formerly GALX -- CS 7/97) announced distribution to The Ale House chain of restaurants with 22 stores throughout FL. Once this contract is fully implemented, GAXCD anticipates revenues in the range of $3.5 million annually. Call Rebecca Barksdale @ 407-855-5500 Ext. 105, or write 2441 Viscount Row, Orlando, FL 32809. [R-7; M-6; L-7] The General Store International Corp. (OTC Bulletin Board/GSIC -- CS 2/98) secured financing, signed an Internet deal 3/9/99, & is poised to launch its Point-of-Sale program 6/10/99. If you have access to the Internet, the text of their news releases and letters to shareholders are posted on www.genstore.com. Call Kyle Werrier @ 888-252-8288, or write 999 3rd Ave, Suite 3260, Seattle, WA 98104 -- email: info@genstore.com [R-7; M-7; L-8] Gentner Communication Corp. (NASDAQ/GTNR -- CS Sneak 2/97) reported a 168% increase in pre-tax earnings to $967,029 ($0.12/share) for Q3 ended 3/31/99. Sales were up 38% to $5,819,151, & net income was up 68% to $606,329 ($0.07/share). Call CFO Susie Strohm @ 800-945-7730 or 801-975-7200, fax 801-977-0087, or write 1825 Research Way, Salt Lake City, UT 84119. sstrohm@ge-ntner.com www.gentner.com [R-5; M-6; L-7] Holt's Cigar Holdings, Inc. (NASDAQ/HOLT -- CS Sneak 12/98) reported its fifteenth consecutive record with sales of $9.3 million. Net earnings were $1.3 million vs. $1.0 million for the same period the previous year. On a comparable share basis, earnings for FY '98 were $0.18 as compared to $0.22 for '99. Call Mary Ann Pentz, IR @ 215-676-8778, fax 215-676-0438, or write 12270 Townsend Rd, Philadelphia, PA 19154. www.holts.com [R-7; M-7; L-8] IGT Pharma Inc. (Formerly IGT International Growth Technologies -- VSE/IGT.V -- CS 7/94) announced the award of a Technology BC industry grant from the Science Council of British Columbia to develop a novel class of podophyllotoxin analogs in the treatment of various cancers. Call president Bruce Schmidt @ 800-743-7444 or write 311-2386 East Mall, University of British Columbia, Vancouver, B.C. Canada V6T 1Z3. [R-5; M-6; L-8] Infinite Group, Inc. (NASDAQ/IMCI --CS Sneak 5/97) acquired Osley & Whitney, Inc., a 45-year-old plastic injection moldbuilding company for $1.5 million, serving such customers as Polaroid, Pitney-Bowes, Hardigg Industries, & Titleist. It also acquired Materials & Manufacturing Technologies, Inc., which recently received a patent on its work in zirconium diboride materials. It also formed Express Pattern, a new rapid prototyping service provider in Buffalo Grove, IL. Call CEO Clifford G. Brockmyre @ 401-738-5777; fax 401-738-6180, or write 2364 Post Rd, Warwick, RI 02886. info@infinite-group.com www.infinite-group.com [R-6; M-6; L-8] Ladd Furniture, Inc. (NASDAQ/LADF -- CS Sneak 6/97) reported FY '98 results: Net sales rose 9%; EBITDA improved 22% (highest since 1989), & gross income increased 14%. Net earnings were $12.3 million or $1.53/diluted share vs. $6.3 million or $0.81/diluted share for FY '97. Call 800-758-5804 Ext 501325, or write 4620 Grandover Pkwy., Box 26777, Greensboro, NC 27417-6777. [R-7; M-7; L-7] ...continued on next page, click here |
|
|
|
Disclaimer: The public companies featured in the Corporate Profiles listed in the "Special Situation" section on the Home Page of www.WallStreetCorner.com are our regular clients. Each such client pays an annual cash fee of $12,000, or alternatively, a monthly cash fee of $495 plus a negotiated number of Form 144 restricted shares for our service. We on rare occasions accept free-trading shares, but we usually hold such shares for the long pull - we do not engage in trading. Such fees are disclosed as part of the Corporate Profile prepared and posted on the particular company involved. The basic coverage provided to such clients primarily includes the preparation of their Corporate Profile, posting it here at WallStreetCorner.com, and the distribution of email alerts to our international database of investors and financial professionals when their Profile is initially posted, and each time their Profile is subsequently updated. We expect our clients to work with us in a team effort by calling us each time they have achieved a significant milestone. We then update their Profile and issue an additional email alert to our totally opt-in email database (as of July 2008, members of that database are from over 96 countries). The email distributions we make are a key element of our service -- those, as well as the updated Corporate Profile are what together are designed to achieve a gradual buildup of new shareholders who generally hold for the long term. If you are an officer at a public company and want the exposure afforded at WallStreetCorner.com, email Larry at up415@aol.com or call him at 843-645-2729. Information displayed by WallStreetCorner in its Corporate Profiles, and in its editorial or other columns, does not constitute an offer to buy, sell, or trade a security of any kind, including stock. Larry Oakley, and/or WallStreetCorner.com, Inc., does not recommend that any person, institution, or other entity make any decisions or form any opinions, etc. based on the information on this site. All visitors to this site are urged to do two things before investing in any stock: (1) Call the company and ask questions -- if there is anything you do not like regarding such call, pass -- our goal is to bring you a selection of what we feel are growth situations with good long-term appreciation potential, but you must accept the responsibility of making your own decisions regarding which situations to invest in -- do not give up that responsibility; and (2) Consult a qualified financial professional before taking any actions in regards to buying, selling, or trading securities (stocks or other forms of equity). Companies covered in Conservative Speculator, a newsletter accessed from WallStreetCorner, or in any of Larry Oakley's other editorial venues ("Opinion," "Stock Pick," "Comment," and "Bold Ventures" columns, and in any other editorial venue to which Larry contributes) do not pay for such editorial coverage; the companies Larry covers editorially have never, do not now, and never will be charged for editorial coverage. The only paid portions of WallStreetCorner.com are the Profiles and email distributions (email distributions are a part of the client's package, but occasionally are paid for separately by non-clients - if a non-client wants to utilize our email distributions, the cost is $2,000 for the first distribution, $1,500 for the second, $1,000 for the third, and $500 for all subsequent distributions made for the same company). On occasion, Larry Oakley shares his opinion regarding a private company or its product or service. Bear in mind that nothing at that special section is an investment possibility. To see that section, click where on the home page it says: "Click here to access our Special Emerging Growth Situations." See the introductory portion of that special section for additional information regarding the material covered there. |
|
|
WallStreetCorner.com |
